Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease
Jeffrey S. Hyams(Connecticut Children's Medical Center), Marla C. Dubinsky(Icahn School of Medicine at Mount Sinai), Robert N. Baldassano(Children's Hospital of Philadelphia), Richard B. Colletti(University of Vermont Children’s Hospital), Salvatore Cucchiara(Sapienza University of Rome), Johanna C. Escher(Erasmus MC - Sophia Children’s Hospital), William A. Faubion(WinnMed), John Fell(Chelsea and Westminster Hospital), Benjamin D. Gold(Children's Center), Anne M. Griffiths(Hospital for Sick Children), Sibylle Koletzko(Ludwig-Maximilians-Universität München), Subra Kugathasan(Emory University), James Markowitz(Cohen Children's Medical Center), Frank M. Ruemmele(Université Paris Cité), Gigi Veereman(Universitair Ziekenhuis Brussel), Harland S. Winter(MaineGeneral Medical Center), Nicholas Masel, Chu Ri Shin(Janssen Scientific Affairs (United States)), Kezhen L. Tang(Janssen (United States)), Meena Thayu(Janssen Scientific Affairs (United States))
Cited by 214
Abstract
Related Papers
No related papers found
Powered by citation graph analysis